Metraipolis › archive › dc_967ec047aa8e
Macitentan and phosphodiesterase-5 inhibitor alone or in combination in newly diagnosed pulmonary arterial hypertension: a pooled analysis — Europe PMC PMID:41568020
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41568020
- DOI
- 10.1016/j.jhlto.2025.100462
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T17:58:42.055Z
- SHA-256 of the archived text
f6ba90fcdba43858c1145b18dbf745ba0f779a18c0da5304fdfa812196d14403- Stable URL of this page
https://metraipolis.com/documento/dc_967ec047aa8e
How to cite
Macitentan and phosphodiesterase-5 inhibitor alone or in combination in newly diagnosed pulmonary arterial hypertension: a pooled analysis — Europe PMC PMID:41568020 — Europe PMC (en), https://europepmc.org/article/MED/41568020 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_967ec047aa8e (Metraipolis archive dc_967ec047aa8e, sha256 f6ba90fcdba43858c1145b18dbf745ba0f779a18c0da5304fdfa812196d14403)
BibTeX
@misc{dc967ec047aa8e,
title = {Macitentan and phosphodiesterase-5 inhibitor alone or in combination in newly diagnosed pulmonary arterial hypertension: a pooled analysis — Europe PMC PMID:41568020},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41568020},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_967ec047aa8e; sha256 f6ba90fcdba43858c1145b18dbf745ba0f779a18c0da5304fdfa812196d14403},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41568020. Agents can read the archived copy with the MCP tool read_document.